Shilpa Medicare Limited (BOM:530549)
India · Delayed Price · Currency is INR 323.30
-8.30 (-2.50%)
At close: Feb 12, 2026
Shilpa Medicare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 14,320 | 12,864 | 11,516 | 10,501 | 11,455 | 9,011 |
Other Revenue | 15 | 15 | 15.04 | 15.65 | 14.11 | 4.56 |
| 14,335 | 12,879 | 11,531 | 10,517 | 11,469 | 9,016 | |
Revenue Growth (YoY) | 14.79% | 11.69% | 9.64% | -8.30% | 27.21% | -0.73% |
Cost of Revenue | 4,666 | 4,540 | 4,435 | 4,604 | 4,315 | 3,136 |
Gross Profit | 9,669 | 8,339 | 7,096 | 5,913 | 7,155 | 5,879 |
Selling, General & Admin | 3,253 | 2,987 | 2,855 | 2,965 | 2,782 | 2,467 |
Other Operating Expenses | 2,592 | 2,267 | 1,871 | 2,043 | 2,328 | 1,679 |
Operating Expenses | 7,024 | 6,385 | 5,805 | 5,967 | 5,950 | 4,692 |
Operating Income | 2,645 | 1,954 | 1,291 | -53.99 | 1,204 | 1,188 |
Interest Expense | -428.57 | -587.65 | -837.14 | -562.55 | -411.1 | -218.69 |
Interest & Investment Income | 80.32 | 80.32 | 13.81 | 17.61 | 20.67 | 34.38 |
Earnings From Equity Investments | 10.98 | -12.65 | -47.78 | -38.1 | -36.6 | -17.36 |
Currency Exchange Gain (Loss) | 131.19 | 131.19 | 84.42 | 140.12 | 66.58 | 99.49 |
Other Non Operating Income (Expenses) | -224.74 | -157.26 | -49.39 | 14.21 | 56.99 | 54.55 |
EBT Excluding Unusual Items | 2,215 | 1,408 | 455.31 | -482.7 | 900.61 | 1,140 |
Gain (Loss) on Sale of Investments | 38.71 | 38.71 | - | - | - | - |
Gain (Loss) on Sale of Assets | -2.71 | -2.71 | 5.44 | -2.65 | -16.02 | -5.93 |
Asset Writedown | -25 | -25 | - | - | - | - |
Other Unusual Items | -324.27 | -195.66 | 82.66 | 102.55 | 138.06 | 678.56 |
Pretax Income | 1,901 | 1,223 | 543.41 | -382.79 | 1,023 | 1,951 |
Income Tax Expense | 400.95 | 440.36 | 223.86 | -73.07 | 416.83 | 488.48 |
Earnings From Continuing Operations | 1,500 | 782.97 | 319.55 | -309.73 | 605.82 | 1,462 |
Minority Interest in Earnings | 0.02 | -0.04 | -0.81 | -15.6 | 0.8 | 15.77 |
Net Income | 1,500 | 782.93 | 318.74 | -325.33 | 606.62 | 1,478 |
Net Income to Common | 1,500 | 782.93 | 318.74 | -325.33 | 606.62 | 1,478 |
Net Income Growth | 69.95% | 145.63% | - | - | -58.95% | -5.36% |
Shares Outstanding (Basic) | 145 | 195 | 174 | 174 | 167 | 163 |
Shares Outstanding (Diluted) | 145 | 195 | 174 | 174 | 167 | 163 |
Shares Change (YoY) | -23.38% | 12.24% | - | 3.91% | 2.46% | - |
EPS (Basic) | 10.33 | 4.02 | 1.84 | -1.87 | 3.63 | 9.06 |
EPS (Diluted) | 10.33 | 4.02 | 1.83 | -1.88 | 3.63 | 9.06 |
EPS Growth | 121.84% | 118.96% | - | - | -59.95% | -5.34% |
Free Cash Flow | - | -1,115 | -478.92 | -467.44 | -2,267 | -3,073 |
Free Cash Flow Per Share | - | -5.72 | -2.76 | -2.69 | -13.57 | -18.85 |
Dividend Per Share | - | 0.500 | - | - | 0.550 | 0.550 |
Gross Margin | 67.45% | 64.75% | 61.54% | 56.22% | 62.38% | 65.21% |
Operating Margin | 18.45% | 15.17% | 11.20% | -0.51% | 10.50% | 13.17% |
Profit Margin | 10.47% | 6.08% | 2.76% | -3.09% | 5.29% | 16.39% |
Free Cash Flow Margin | - | -8.65% | -4.15% | -4.45% | -19.77% | -34.09% |
EBITDA | 3,785 | 3,056 | 2,343 | 865.45 | 1,972 | 1,709 |
EBITDA Margin | 26.40% | 23.73% | 20.32% | 8.23% | 17.20% | 18.96% |
D&A For EBITDA | 1,139 | 1,102 | 1,052 | 919.44 | 768.03 | 521.76 |
EBIT | 2,645 | 1,954 | 1,291 | -53.99 | 1,204 | 1,188 |
EBIT Margin | 18.45% | 15.17% | 11.20% | -0.51% | 10.50% | 13.17% |
Effective Tax Rate | 21.09% | 36.00% | 41.20% | - | 40.76% | 25.04% |
Revenue as Reported | 14,484 | 13,096 | 11,598 | 10,675 | 11,598 | 9,313 |
Advertising Expenses | - | 45.6 | 28.68 | 26.23 | 56.59 | 35.17 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.